Clinical trialsOfficial

ANSM bans direct furosemide sales to pharmacies and allows compounded capsules amid shortage

🇫🇷 ANSM · Wed 18 Nov 2026

France's medicines agency expects furosemide 20 mg and 40 mg tensions to last several months into 2027, and is adding supply, distribution and substitution measures.

ANSM said on 18 November 2026 that severe supply tensions affecting furosemide 20 mg and 40 mg medicines are continuing and should last several more months in 2027. It attributes the ongoing difficulties to supply problems at Viatris, and says it is reinforcing earlier measures and adding new ones to limit the risk of treatment interruptions.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: ANSM ↗

Article written by VigiEye from the official source (ANSM). AI-assisted; check the source before acting.